11% Of Those With Type 1 Diabetes Served By FQHCs Are Prescribed Continuous Glucose Monitoring

About 11% of those with Type 1 diabetes (T1D) who are served by federally qualified health centers (FQHCs) are prescribed continuous glucose monitoring (CGM) technology. For those with Type 2 diabetes (T2D), the CGM prescribing rate in FQHCs was just 1%. However, CGM prescription rates did increase between 2014 and 2021.

The uptake of CGM is highest in endocrinology clinics, which provide diabetes care for people with T1D and those with complex T2D. About 46% of this population are prescribed CGMs. In primary care clinics, where the majority of T2D treatment is provided, the rate of CGM utilization is lower . . .